API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
Details:
Mupirocin cream USP, 2% is indicated for the treatment of secondarily infected traumatic skin lesions due to susceptible strains of S. aureus and S. pyogenes.
Lead Product(s): Mupirocin
Therapeutic Area: Infections and Infectious Diseases Product Name: Mupirocin
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Alembic Pharmaceuticals Limited
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable November 17, 2021